These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 18607310

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis.
    Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA.
    Sex Transm Dis; 2002 Nov; 29(11):655-64. PubMed ID: 12438901
    [Abstract] [Full Text] [Related]

  • 23. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR.
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Preclinical assessments of vaginal microbicide candidate safety and efficacy.
    Fernández-Romero JA, Teleshova N, Zydowsky TM, Robbiani M.
    Adv Drug Deliv Rev; 2015 Sep 15; 92():27-38. PubMed ID: 25543007
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Preparing for efficacy trials of vaginal microbicides in Indian women.
    Joshi S, Solomon S, Mayer K, Mehendale S.
    Indian J Med Res; 2005 Apr 15; 121(4):502-9. PubMed ID: 15817959
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Biomarkers for evaluating vaginal microbicides and contraceptives: discovery and early validation.
    Mauck CK.
    Sex Transm Dis; 2009 Mar 15; 36(3 Suppl):S73-5. PubMed ID: 19218892
    [Abstract] [Full Text] [Related]

  • 35. Microbicides for the prevention of HIV infection in women: an overview of recent trials.
    Rosenberg ZF, Nel A, Heyward W, Mitchnick M.
    Curr Opin HIV AIDS; 2006 Nov 15; 1(6):514-9. PubMed ID: 19372855
    [Abstract] [Full Text] [Related]

  • 36. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS, Ngoh N, Roddy R, Lai JJ, Linton K, Mauck C.
    Contraception; 2007 Sep 15; 76(3):245-9. PubMed ID: 17707724
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vaginal microbicides: where are we and where are we going?
    Moscicki AB.
    J Infect Chemother; 2008 Oct 15; 14(5):337-41. PubMed ID: 18936885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.